COTA, FDA Agree to Collaborate on Breast Cancer Research

May 30, 2019 – COTA, Inc., a leading precision medicine technology company, has signed a 2-year Research Collaboration Agreement (RCA) with the FDA’s Information Exchange and Data Transformation (INFORMED) program. The agreement establishes a study protocol for research into disparities in treatment and outcomes for patients with breast cancer. Only 3% to 5% of adults with cancer are enrolled in traditional clinical trials, COTA said in a news release. The FDA … (leggi tutto)